Nicholas Funderburg

The paper uses metabolomics to show that HIV-treated individuals have metabolic disruptions, including lipid changes and inflammation markers, despite viral suppression.

This study links microbial dysbiosis, systemic inflammation, and metabolomic disruptions to SNAE risk in treated HIV patients through multi-omic analysis.

This study examines the cervicovaginal microbiome of HIV-positive pregnant people in the DRC, finding taxonomic and functional differences compared to HIV-negative individuals and linking microbiome features to adverse pregnancy outcomes.